Aug. 8–9, 2024 in Chicago or virtual from Aug. 22–23, 2024 Applications for the in-person and virtual programs were due April 3, 2024, at 5 p.m
April 21–22, 2022 • San Diego, CA & Virtually View Schedule | Registration Rates | Meeting Code of Conduct ORGANIZERS Christian M
The event will be preceded by an outstanding Pre-Symposium Biotech Forum on 22 September, 2022. PMFG 2022 is a four-day in-person symposium with pre- and post-conference workshops, and a satellite half-day meeting centered on two major themes: How cellular, organoid, and animal models are being used to facilitate the discovery of basic disease mechanisms and potential cures The development of advanced therapies to treat diseases Objectives: Find out how National and International Programs are being developed to ensure a Precision Medicine ecosystem worldwide Describe how clinical trial networking is critical for evaluating advanced treatments in pediatric, rare disorders Describe the recent applications of Precision Medicine approaches in Pediatric Cancer Immunotherapy Learn about novel technologies driving recent advances in the field of translational genomics Learn about recent efforts using animal, cellular, and organoid models for human disease modeling Event Chairs: Chiara Cugno, MD, Director, Advanced Cell Therapy Core Luis R
09-23-2022 14:00 - 09-26-2022 16:15 AT Doha
June is Cancer Immunotherapy Month™, and I could not think of a better scientist and person to host for this month’s fireside chat than Steven A...For more information about attending SITC 2021 in person and virtually, visit the FAQ page
Quick-reference tables summarizing pivotal trial data for approved immunotherapy agents for GI cancer. Add a tag
FOR IMMEDIATE RELEASE Oct. 22, 2021 MILWAUKEE – The Society for Immunotherapy of Cancer (SITC) is pleased to announce BioNTech cofounders Uğur Şahin, MD and Özlem Türeci, MD as the recipients of the SITC Medal of Honor for the development of the vaccine against COVID-19
Recombinant IL-2, IL-12, and IL-15 superagonist tagged with a naturally phosphorylated peptide motif (called alum-binding protein (ABP)) were robustly and consistently phosphorylated when purified from Fam20C kinase-expressing HEK293-F cells. ABP-tagged cytokines remained absorbed on alum for more than 2 weeks in vitro in the presence of mouse serum and largely retained functional bioactivity
Take a selfie or group photo and tag SITC on social media to help us spread the word about cancer immunotherapy research
Frequently Asked Questions Join us in person in San Diego, CA, or virtually, for SITC's 38th Annual Meeting & Pre-Conference Programs (SITC 2023). Registration FAQs Continuing Ed FAQs Registration Frequently Asked Questions Can I register for both virtual and in-person programs? The SITC 2023 online registration platform will allow attendees to select from in-person and or virtual programs
Join
Renew
Member Directory
My Profile
Email Sign-up
Volunteer
Support SITC
Contact Us